Tango Therapeutics (TNGX) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free TNGX Stock Alerts $7.80 +0.20 (+2.63%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tango Therapeutics Short Interest DataCurrent Short Volume10,890,000 sharesPrevious Short Volume10,630,000 sharesChange Vs. Previous Month+2.45%Dollar Volume Sold Short$83.85 millionShort Interest Ratio / Days to Cover17.7Last Record DateApril 30, 2024Outstanding Shares106,850,000 sharesFloat Size54,880,000 sharesShort Percent of Float19.84%Today's Trading Volume612,793 sharesAverage Trading Volume628,798 sharesToday's Volume Vs. Average97% Short Selling Tango Therapeutics ? Sign up to receive the latest short interest report for Tango Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTNGX Short Interest Over TimeTNGX Days to Cover Over TimeTNGX Percentage of Float Shorted Over Time Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Tango Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,890,000 shares $83.85 million +2.5%19.8%17.7 $7.70 4/15/202410,630,000 shares $77.81 million +4.3%19.4%17.6 $7.32 3/31/202410,190,000 shares $80.91 million +14.8%19.4%14.6 $7.94 3/15/20248,880,000 shares $80.19 million +0.1%16.9%13.4 $9.03 2/29/20248,870,000 shares $98.72 million -7.4%17.7%14.4 $11.13 2/15/20249,580,000 shares $113.24 million -8.9%19.1%15.1 $11.82 Get the Latest News and Ratings for TNGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tango Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202410,510,000 shares $123.49 million +0.6%20.6%16.2 $11.75 1/15/202410,450,000 shares $114.32 million +2.7%20.5%14.9 $10.94 12/31/202310,180,000 shares $100.78 million +8.2%19.9%9.9 $9.90 12/15/20239,410,000 shares $100.12 million -3.6%18.4%8.3 $10.64 11/30/20239,760,000 shares $74.18 million +4.5%19.2%7.9 $7.60 11/15/20239,340,000 shares $67.57 million +10.7%18.4%7.7 $7.24 10/31/20238,440,000 shares $70.90 million +23.0%16.1%3.3 $8.40 10/15/20236,860,000 shares $52.75 million +29.4%13.0%2.8 $7.69 9/30/20235,300,000 shares $59.68 million +49.7%11.4%2.6 $11.26 9/15/20233,540,000 shares $30.13 million +37.2%7.6%2 $8.51 8/31/20232,580,000 shares $16.74 million -7.9%5.6%1.6 $6.49 8/15/20232,800,000 shares $19.32 million +71.8%6.9%1.7 $6.90 7/31/20231,630,000 shares $5.51 million +8.7%3.8%1.2 $3.38 7/15/20231,500,000 shares $5.15 million -1.3%3.5%7.8 $3.43 6/30/20231,520,000 shares $5.05 million +1.3%3.5%7.3 $3.32 6/15/20231,500,000 shares $5.42 million -18.5%3.5%6.6 $3.61 5/31/20231,840,000 shares $4.97 million +1.1%3.6%8.2 $2.70 5/15/20231,820,000 shares $6.86 million -18.0%3.6%11 $3.77 4/30/20232,220,000 shares $7.55 million -11.9%4.4%11 $3.40 4/15/20232,520,000 shares $10.74 million -2.0%5.0%12 $4.26 3/31/20232,570,000 shares $10.15 million +9.4%5.1%12.8 $3.95 3/15/20232,350,000 shares $10.06 million +2.2%4.7%12.3 $4.28 2/28/20232,300,000 shares $12.03 million +8.0%4.6%11 $5.23 2/15/20232,130,000 shares $12.10 million +43.9%4.2%9.6 $5.68 1/31/20231,480,000 shares $9.77 million +3.5%2.9%7.2 $6.60 1/15/20231,430,000 shares $11.53 million -2.1%2.9%7.1 $8.06 12/30/20221,460,000 shares $10.59 million +33.9%2.9%6.8 $7.25 12/15/20221,090,000 shares $8.63 million -14.8%2.2%5.1 $7.92 11/30/20221,280,000 shares $9.61 million -0.8%2.8%5.8 $7.51 11/15/20221,290,000 shares $10.45 million +3.2%2.9%6.1 $8.10 10/31/20221,250,000 shares $10.05 million +13.6%2.8%6.2 $8.04 10/15/20221,100,000 shares $5.69 million +3.8%2.4%5.1 $5.17 9/30/20221,060,000 shares $3.84 million -24.3%2.4%4.8 $3.62 9/15/20221,400,000 shares $5.01 million +7.7%3.1%4 $3.58Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge TNGX Short Interest - Frequently Asked Questions What is Tango Therapeutics' current short interest? Short interest is the volume of Tango Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 10,890,000 shares of TNGX short. 19.84% of Tango Therapeutics' shares are currently sold short. Learn More on Tango Therapeutics' current short interest. What is a good short interest ratio for Tango Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNGX shares currently have a short interest ratio of 18.0. Learn More on Tango Therapeutics's short interest ratio. What is a good short interest percentage for Tango Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.84% of Tango Therapeutics' floating shares are currently sold short. Is Tango Therapeutics' short interest increasing or decreasing? Tango Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 10,890,000 shares, an increase of 2.4% from the previous total of 10,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tango Therapeutics' float size? Tango Therapeutics currently has issued a total of 106,850,000 shares. Some of Tango Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tango Therapeutics currently has a public float of 54,880,000 shares. How does Tango Therapeutics' short interest compare to its competitors? 19.84% of Tango Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Tango Therapeutics: Dianthus Therapeutics, Inc. (9.95%), Arcturus Therapeutics Holdings Inc. (20.02%), Evolus, Inc. (9.69%), Zentalis Pharmaceuticals, Inc. (24.64%), Longboard Pharmaceuticals, Inc. (13.02%), ALX Oncology Holdings Inc. (11.46%), Disc Medicine, Inc. (12.97%), Praxis Precision Medicines, Inc. (5.06%), Pliant Therapeutics, Inc. (12.51%), ARS Pharmaceuticals, Inc. (15.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Tango Therapeutics stock? Short selling TNGX is an investing strategy that aims to generate trading profit from Tango Therapeutics as its price is falling. TNGX shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tango Therapeutics? A short squeeze for Tango Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNGX, which in turn drives the price of the stock up even further. How often is Tango Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNGX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: DNTH Short Interest ARCT Short Interest EOLS Short Interest ZNTL Short Interest LBPH Short Interest ALXO Short Interest IRON Short Interest PRAX Short Interest PLRX Short Interest SPRY Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNGX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts